Very smart assumption. I too wondered what the dosing regimen might be! I suspect they will need to use the 2nd dosing tier, as this demonstrated the best viral replication and response.
Keep up the good work!
As an exercise and if you are interested, I would spend significant time reviewing the HER-Vaxx data. This is the data announced by IMU, the specific studies published on HER-Vaxx, associated studies of Herceptin and Enhertu, as well as studies evaluating clinical and commercial success.
I saw many things that crippled HER-Vaxx clinically and commercially that almost everyone missed. There are real clues you can use to evaluate CF33 and avoid the same mistakes. No need to share it. Most holders are too emotionally invested to listen. If you want to discuss it, happy to give you my email.
- Forums
- ASX - By Stock
- IMU
- Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-291
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M |
Open | High | Low | Value | Volume |
5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 1854997 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 382882 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 1694499 | 0.052 |
37 | 4870470 | 0.051 |
51 | 4160179 | 0.050 |
17 | 2263068 | 0.049 |
19 | 954663 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 282882 | 3 |
0.054 | 2751851 | 4 |
0.055 | 1611272 | 15 |
0.056 | 2792035 | 11 |
0.057 | 700330 | 7 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |